Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

10x Genomics, Inc.

TXG · Nasdaq · CIK 0001770787 · Healthcare · Medical Devices

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

46 Form 4 transaction lines observed in the same window
38 sales · 8 option, withholding, award, gift or other lines

Last qualifying purchase2025-02-21 · MATEO ALAN · $445.6K

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesHigh
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Saxonov SergeChief Executive Officer
▼▼▼○▼▼○▼
SULIMAN SHEHNAAZDirector
○▼▼▼
Teichmann Sarah A.Director
○▼▼
STUELPNAGEL JOHN RDirector
○▼▼
Taich AdamChief Financial Officer
▼▼▼
Hindson Benjamin J.See Remarks
▼▼
● Purchase▼ Sale○ Other

Showing the six most active owners; 3 additional owner(s) remain in Form 4 evidence.

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2025-02-21 · MATEO ALAN.

Recent Form 4 activity

0Purchases
50Sales
13Other Form 4 lines
38SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING38 sale line(s) · context only
OTHER8 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
15,371,598
Previous report
16,692,300
Avg daily volume
3,393,658
Days to cover
4.5

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2025-02-21MATEO ALANPurchase (P)Class A Common Stock40,000USD 11.14USD 445,600SEC filing ↗
2022-05-13McAnear Justin J.Purchase (P)Class A Common Stock158USD 40.49USD 6,397SEC filing ↗
2022-05-13CRUTCHFIELD BRADFORDPurchase (P)Class A Common Stock158USD 40.49USD 6,397SEC filing ↗

Form 4 evidence

63 transaction lines in the latest 365-day window; 1,221 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-22Saxonov SergeSale (S)Class A Common Stock25,000USD 81.22USD 2,030,593SEC filing ↗
2026-09-22SULIMAN SHEHNAAZSale (S)Class A Common Stock5,723USD 81.19USD 464,677SEC filing ↗
2026-09-09Taich AdamSale (S)Class A Common Stock46,388USD 64.58USD 2,995,519SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-22Saxonov SergeSale (S)Class A Common Stock25,000USD 81.22USD 2,030,593SEC filing ↗
2026-09-22SULIMAN SHEHNAAZSale (S)Class A Common Stock5,723USD 81.19USD 464,677SEC filing ↗
2026-09-09Taich AdamSale (S)Class A Common Stock46,388USD 64.58USD 2,995,519SEC filing ↗
2026-09-03STUELPNAGEL JOHN RSale (S)Class A Common Stock20,000USD 61.76USD 1,235,120SEC filing ↗
2026-09-01Saxonov SergeGift (G)Class A Common Stock100USD 0.00USD 0SEC filing ↗
2026-08-26Saxonov SergeSale (S)Class A Common Stock10,486USD 63.70USD 667,913SEC filing ↗
2026-08-24Taich AdamSale (S)Class A Common Stock17,166USD 63.02USD 1,081,801SEC filing ↗
2026-08-24Saxonov SergeSale (S)Class A Common Stock18,545USD 63.02USD 1,168,706SEC filing ↗
2026-08-24SULIMAN SHEHNAAZSale (S)Class A Common Stock2,207USD 63.65USD 140,486SEC filing ↗
2026-08-24Hindson Benjamin J.Sale (S)Class A Common Stock13,818USD 63.02USD 870,810SEC filing ↗
2026-08-20Saxonov SergeGift (G)Class A Common Stock4,000USD 0.00USD 0SEC filing ↗
2026-08-14Teichmann Sarah A.Sale (S)Class A Common Stock2,273USD 57.15USD 129,902SEC filing ↗
2026-08-13Teichmann Sarah A.Sale (S)Class A Common Stock5,278USD 57.29USD 302,377SEC filing ↗
2026-08-11STUELPNAGEL JOHN RSale (S)Class A Common Stock20,000USD 57.75USD 1,155,050SEC filing ↗
2026-06-22Saxonov SergeSale (S)Class A Common Stock30,000USD 34.44USD 1,033,295SEC filing ↗
2026-06-16SULIMAN SHEHNAAZSale (S)Class A Common Stock5,723USD 32.63USD 186,760SEC filing ↗
2026-06-04Teichmann Sarah A.Award / grant (A)Class A Common Stock8,829USD 0.00USD 0SEC filing ↗
2026-06-04SULIMAN SHEHNAAZAward / grant (A)Class A Common Stock8,829USD 0.00USD 0SEC filing ↗
2026-06-04STUELPNAGEL JOHN RAward / grant (A)Class A Common Stock8,829USD 0.00USD 0SEC filing ↗
2026-06-04Popovits Kimberly JAward / grant (A)Class A Common Stock8,829USD 0.00USD 0SEC filing ↗
2026-06-04MATEO ALANAward / grant (A)Class A Common Stock8,829USD 0.00USD 0SEC filing ↗
2026-06-04Kosaraju SridharAward / grant (A)Class A Common Stock8,829USD 0.00USD 0SEC filing ↗
2026-05-26Saxonov SergeSale (S)Class A Common Stock10,718USD 24.71USD 264,842SEC filing ↗
2026-05-22Taich AdamSale (S)Class A Common Stock15,098USD 24.44USD 368,995SEC filing ↗
2026-05-22Saxonov SergeSale (S)Class A Common Stock18,175USD 24.44USD 444,197SEC filing ↗
2026-05-22Hindson Benjamin J.Sale (S)Class A Common Stock11,595USD 24.44USD 283,382SEC filing ↗
2026-04-14Saxonov SergeSale (S)Class A Common Stock5,000USD 24.56USD 122,800SEC filing ↗
2026-03-24Saxonov SergeSale (S)Class A Common Stock5,000USD 19.52USD 97,600SEC filing ↗
2026-03-23Saxonov SergeSale (S)Class A Common Stock10,000USD 19.13USD 191,300SEC filing ↗
2026-03-03Saxonov SergeGift (G)Class A Common Stock2,750USD 0.00USD 0SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerTXG
CIK0001770787
SectorHealthcare
IndustryMedical Devices Yahoo Finance
SEC SIC3826 Laboratory Analytical Instruments
ExchangeNasdaq

Data coverage

Local Form 4 history1,221 transaction lines from 2020-01-03 to 2026-09-22
3 P purchase lines · 936 S sale lines · 282 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.